CAJ | 학술논문

目的：探讨复发转移食管癌患者的预后影响因素，为患者复发转移后的临床治疗提供参考。方法回顾性分析247例食管鳞癌根治性切除术后复发转移患者的临床资料，结合随访资料进行预后因素分析。采用Kaplan?Meier法进行生存分析，组间比较采用Log rank法，以Cox比例风险模型进行多因素分析。结果247例复发转移食管癌患者中，局部复发139例（56．3％），远处转移60例（24．3％），混合型复发48例（19．4％）。247例患者的生存时间为1～42个月，中位生存时间为10个月。复发转移后1、2、3年生存率分别为26．4％、6．3％和2．4％。单因素分析显示，原发肿瘤区域淋巴结转移、远处淋巴结转移、临床分期、术后与复发转移间隔时间、复发转移方式、复发转移后治疗方法与复发转移食管癌患者的预后有关（均P＜0．05）。多因素分析显示，原发肿瘤临床分期、术后与复发转移间隔时间、复发转移方式、复发转移后治疗方法均为影响预后的独立因素（均P＜0．05）。结论复发转移食管癌患者的预后差，预后受多种因素影响，积极采用综合治疗有助于延长患者的生存时间。
목적：탐토복발전이식관암환자적예후영향인소，위환자복발전이후적림상치료제공삼고。방법회고성분석247례식관린암근치성절제술후복발전이환자적림상자료，결합수방자료진행예후인소분석。채용Kaplan?Meier법진행생존분석，조간비교채용Log rank법，이Cox비례풍험모형진행다인소분석。결과247례복발전이식관암환자중，국부복발139례（56．3％），원처전이60례（24．3％），혼합형복발48례（19．4％）。247례환자적생존시간위1～42개월，중위생존시간위10개월。복발전이후1、2、3년생존솔분별위26．4％、6．3％화2．4％。단인소분석현시，원발종류구역림파결전이、원처림파결전이、림상분기、술후여복발전이간격시간、복발전이방식、복발전이후치료방법여복발전이식관암환자적예후유관（균P＜0．05）。다인소분석현시，원발종류림상분기、술후여복발전이간격시간、복발전이방식、복발전이후치료방법균위영향예후적독립인소（균P＜0．05）。결론복발전이식관암환자적예후차，예후수다충인소영향，적겁채용종합치료유조우연장환자적생존시간。
Objective The aim of this study was to explore the influencing factors of prognosis for recurrent and metastatic esophageal carcinoma, and to provide reference for clinical treatment for these patients. Methods The clinicopathological and follow?up data of 247 patients with recurrent and metastatic esophageal squamous cell carcinoma after radical resection were retrospectively reviewed, combined with analysis of prognostic factors in these patients. Kaplan?Meier method was used to analyze the survival, difference between groups was compared by Log rank test, and Cox model was used for multivariate analysis. Results Among the 247 recurrent and metastatic patients, locoregional recurrence was in 139 patients (56. 3%), distant metastasis in 60 patients (24. 3%), and combined recurrence in 48 patients (19. 4%). The survival time was 1 to 42 months in the 247 patients, and the median survival time was 10 months. The 1?, 3?and 5?year survival rate after recurrence and metastasis was 26. 4%, 6. 3% and 2. 4%, respectively. Univariate analysis indicated that regional lymph node metastasis of the primary tumor, distant lymph node metastasis, clinical staging, interval between operation and recurrence, recurrent and metastatic patterns, and treatment methods after recurrence and metastasis were influencing factors of prognosis (all P<0. 05). Cox multivariate analysis indicated that clinical staging of the primary tumor, interval between operation and recurrence, recurrent and metastatic patterns, and treatment methods after recurrence and metastasis were independent factors influencing prognosis (all P <0. 05). Conclusions The prognosis of patients with recurrent and metastatic esophageal carcinoma is poor, and it is affected by many factors. Comprehensive treatment is effective in prolonging the survival time of the patients.